How Much Does AndroGel Cost in Vermont in 2026?

Vermont Retail Pricing for AndroGel in 2026

Brand-name AndroGel 1.62% carries a manufacturer list price set by AbbVie of $510 per month, and Vermont retail pharmacy prices track closely to that figure. The price reflects a 30-day supply of the 1.62% pump formulation, the most commonly prescribed version.

Pricing varies modestly across the state. Pharmacies in Burlington, Montpelier, and Rutland typically charge within $5 to $15 of the list price for cash-pay customers. Independent pharmacies may offer slightly lower pricing than chain retailers, though the difference rarely exceeds 10%. Vermont does not impose its own drug pricing caps beyond federal requirements for Medicaid rebates.

The authorized generic version of testosterone gel 1.62%, manufactured by Teva and other companies, costs between $350 and $430 per month at Vermont retail pharmacies. That represents a 15% to 30% discount compared to brand AndroGel. Both formulations contain the same active ingredient (testosterone) at the same concentration and are rated therapeutically equivalent by the FDA under its Orange Book classification system [1]. For patients paying cash, the generic is the better value. For those with insurance, the copay difference between brand and generic depends entirely on formulary tier placement.

Vermont Medicaid Coverage and Prior Authorization

Vermont Medicaid covers AndroGel, but only after prior authorization (PA). The PA process requires documentation of a clinical diagnosis of male hypogonadism, confirmed by at least two morning serum testosterone levels below 300 ng/dL, consistent with the Endocrine Society's 2018 clinical practice guideline [2].

The PA request must include the prescribing clinician's NPI, the patient's lab results with dates, and a brief clinical rationale. Vermont's Department of Vermont Health Access (DVHA) typically processes PA requests within 72 hours. Approval is granted for 12 months and requires renewal with updated labs.

Once approved, Vermont Medicaid beneficiaries pay $0 to $3 per prescription depending on their specific plan tier. Vermont expanded Medicaid under the ACA covers adult men who meet income thresholds, and testosterone replacement therapy falls under the pharmacy benefit. The state does not separately restrict testosterone gel under a mental health or specialty carve-out.

One procedural detail matters here. If the PA is denied, Vermont Medicaid allows a one-level appeal within 30 days. Denials most commonly occur when lab values fall in the borderline range (280 to 350 ng/dL) or when the clinical notes do not document symptoms such as fatigue, decreased libido, or reduced muscle mass alongside the lab findings. Including symptom documentation in the initial PA request reduces denial rates substantially.

Commercial Insurance Coverage in Vermont

Most commercial health plans sold in Vermont, including those on Vermont Health Connect (the state exchange), cover testosterone gel on their formularies. Blue Cross Blue Shield of Vermont, MVP Health Care, and Cigna all list either brand AndroGel or its authorized generic on their 2026 formularies, typically on Tier 2 (preferred brand) or Tier 3 (non-preferred brand).

Copays range from $30 to $75 per month depending on the plan and tier. High-deductible health plans (HDHPs) require patients to pay full price until meeting their deductible, which means the $510 monthly cost applies out of pocket during the deductible phase. After the deductible, coinsurance of 20% to 40% is typical, bringing the monthly cost to $102 to $204.

Step therapy requirements are common. Several Vermont commercial plans require patients to try injectable testosterone (cypionate or enanthate) before approving topical gel. Injectable testosterone cypionate costs $30 to $75 per month, making it the lowest-cost option by a wide margin. If a patient fails injectable therapy (due to injection site reactions, fear of needles, or preference for steady-state delivery), plans generally approve the step-therapy exception for gel within one to two prior authorization cycles.

The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies enrolling 790 men aged 65 and older with serum testosterone below 275 ng/dL, demonstrated that testosterone gel (1.62%) improved sexual function, physical function (6-minute walk distance increased by 33 meters vs. placebo), and mood over 12 months [3]. These data support the clinical rationale that insurance companies use when evaluating coverage requests for testosterone gel in older men.

The AbbVie Savings Card in Vermont

AbbVie offers a manufacturer copay savings card for AndroGel that can reduce out-of-pocket costs for commercially insured patients. The card is not available to patients covered by Medicare, Medicaid, Tricare, or other government-funded programs. That exclusion is a federal requirement under the Anti-Kickback Statute, not a Vermont-specific restriction.

For eligible patients, the savings card covers up to $75 per month in copay costs. If a patient's copay is $50, the card covers the full amount, bringing the cost to $0. If the copay is $100, the card reduces it to $25. The annual maximum benefit is typically $900 to $1,200 per calendar year, though AbbVie adjusts these figures periodically.

Enrollment is straightforward. Patients can register online through AbbVie's patient assistance portal or receive an activation card from their prescribing clinician. The card works at any Vermont pharmacy that accepts commercial copay cards, which includes all major chains and most independents. Processing happens at the point of sale through the pharmacy's claims adjudication system.

Vermont does not have a copay accumulator law that would prevent savings card payments from counting toward a patient's deductible or out-of-pocket maximum. This is a meaningful distinction. In states with accumulator programs, manufacturer copay assistance does not reduce the patient's deductible obligation, effectively forcing patients to pay twice. Vermont patients benefit from the absence of this restriction: every dollar the AbbVie card pays counts toward the plan's deductible and annual out-of-pocket cap.

Compounded Testosterone Gel in Vermont

Compounded testosterone gel is legal in Vermont when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. The typical cost is approximately $120 per month, a 76% reduction compared to brand AndroGel.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients based on a valid prescription. Vermont's Board of Pharmacy regulates these pharmacies under 21 V.S.A. Chapter 36 and requires them to meet USP Chapter 795 standards for non-sterile compounding [4]. Topical testosterone gel is classified as a non-sterile preparation, so USP 795 (not the more stringent USP 797 for sterile compounds) applies.

Several 503A pharmacies in Vermont compound testosterone gel in concentrations matching commercial products (1% and 1.62%). The compounded version is not FDA-approved and does not carry the same bioequivalence data as the authorized generic. Dr. Bradley Anawalt, an endocrinologist at the University of Washington and co-author of the Endocrine Society testosterone guidelines, has stated: "Compounded testosterone products can be a reasonable option when cost is a barrier, but patients should understand that these products have not undergone the same regulatory review as FDA-approved formulations" [5].

The practical tradeoff is cost versus regulatory assurance. Compounded gel at $120 per month saves $390 monthly compared to brand AndroGel. Over a year, that difference is $4,680. For patients on a fixed income or without insurance, compounded gel may be the only financially viable option for ongoing testosterone replacement.

One caution: 503B outsourcing facilities, which compound without patient-specific prescriptions in larger batches, are regulated by the FDA rather than state boards. Vermont permits 503B-compounded testosterone gel when the facility is registered with the FDA and the product is distributed to a licensed prescriber or pharmacy. The pricing from 503B facilities is generally comparable to 503A pricing.

Telehealth Prescribing of Testosterone in Vermont

Vermont permits telehealth prescribing of testosterone gel, including initial prescriptions for new patients. The state's telehealth parity law (Act 7 of 2023) requires insurers to cover telehealth visits at the same rate as in-person visits, and it does not exclude controlled substances from telehealth prescribing.

Federal DEA regulations historically required an in-person evaluation before prescribing Schedule III controlled substances via telehealth. The DEA's 2025 final rule on telemedicine prescribing extended temporary flexibilities that allow initial prescriptions of Schedule III through V substances via audio-video telehealth encounters without a prior in-person visit [6]. Testosterone gel, classified as Schedule III, falls within this provision.

This means a Vermont resident can consult with a licensed clinician via video, receive a diagnosis of hypogonadism based on prior lab work, and obtain a prescription for testosterone gel without setting foot in a clinic. The clinician must be licensed in Vermont or hold a valid compact license, and the prescription must be sent to a Vermont-licensed pharmacy.

For patients in rural parts of the state (the Northeast Kingdom, for example, where the nearest endocrinologist may be 60 or more miles away), telehealth removes a significant access barrier. Lab work can be completed at any Quest, LabCorp, or hospital-affiliated draw station, and results are shared electronically with the telehealth provider.

How to Minimize Your AndroGel Cost in Vermont

The cheapest path depends on insurance status. Here is a decision framework ranked by out-of-pocket cost.

Uninsured or high-deductible plan (pre-deductible): Compounded testosterone gel from a Vermont 503A pharmacy at approximately $120 per month is the lowest-cost option. Ask your prescriber to write the prescription for compounded testosterone gel 1.62% and specify the compounding pharmacy.

Commercially insured with copay: Use the AbbVie savings card to offset your copay. If your plan covers the authorized generic at a lower tier, ask your pharmacist to process the generic first and apply the savings card only if needed.

Vermont Medicaid: File the prior authorization with complete documentation (two morning testosterone levels below 300 ng/dL, symptom checklist, prescriber clinical note). Your cost will be $0 to $3 after approval.

Medicare Part D: AndroGel is covered under most Part D formularies, but the donut hole (coverage gap) can push costs above $100 per month during the gap phase. The Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D spending, fully effective in 2025, limits total annual drug costs. For a patient using only AndroGel, the cap means roughly 4 to 5 months of full-price payments before costs drop to $0 for the remainder of the year [7].

Injectable alternative: If cost is the primary concern and you are comfortable with self-injection, testosterone cypionate at $30 to $75 per month (with insurance often covering it at Tier 1) is the lowest absolute cost for testosterone replacement. The Endocrine Society guideline considers injectables and gels therapeutically equivalent for treating hypogonadism [2].

Comparing AndroGel to Other Testosterone Formulations in Vermont

Testosterone replacement comes in several delivery systems, each with different pricing in Vermont.

Testosterone cypionate injections (intramuscular, every 1 to 2 weeks) cost $30 to $75 per month and are the least expensive option. Peak-and-trough fluctuations in serum testosterone levels can cause mood variability in some patients.

Testosterone enanthate injections carry similar pricing and pharmacokinetics to cypionate. Both are available as generics from multiple manufacturers.

Natesto (testosterone nasal gel, 4.5%) costs approximately $550 to $650 per month in Vermont. It requires application two to three times daily. It avoids the transference risk associated with topical gels but has limited insurance coverage.

Testosterone patches (Androderm) cost $400 to $550 per month. Skin irritation at the application site is the most common reason patients switch from patches to gel [8].

AndroGel 1% (the older formulation, now available as generic) costs $280 to $380 per month. The 1.62% formulation was developed to deliver the same testosterone dose in a smaller volume of gel, improving convenience. Both concentrations achieve similar steady-state serum testosterone levels when dosed appropriately, according to pharmacokinetic data in the FDA-approved prescribing information [1].

For Vermont patients whose primary concern is minimizing cost while using a topical formulation, compounded testosterone gel at $120 per month or generic testosterone gel 1% at $280 per month are the two most practical options.